MACCE
1 paper1 finding
- Humans1
Associations
1Nocturnal VLF
upin humans1
1 study
Nocturnal VLF
upin humans1
Nocturnal VLF predicts MACCE in humans (aHR 1.25, 95% CI 1.10–1.43).
“Patients with decreased per VLF standard deviation (629.92 ms 2 ) had a higher cumulative risk of MACCEs (adjusted hazard ratio [aHR] 1.25, 95% confidence interval [CI], 1.10–1.43, P=0.001).”
Humansprospective cohort undergoing nocturnal Holter monitoring and HSAT3.1 yearsn = 1,925
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
12 in 12 monthsFrontiers in Endocrinology
Linking the triglyceride-glucose index to major adverse cardiocerebrovascular events in individuals with cardiovascular-kidney-metabolic syndrome: insights from an aggregate-data systematic review and dose-response meta-analysis
Meta-analysis of observational studiesTriglyceride-glucose index
Drug Design, Development and Therapy
Prior Use of GLP-1 Receptor Agonists versus SGLT2 Inhibitors and Clinical Outcomes After Sepsis in Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study
Cohort study of 11,969 peopleSepsis
Muscles
Sex-Specific Differences in Patients with Sarcopenia and Peripheral Artery Disease
Cohort study of 3,282 peoplePeripheral artery disease
Journal of the American Heart Association
Post-traumatic Psychopathology and Cardiovascular Risk: A Danish Case-Control Study of Sex-Specific Associations
Case-control study in peoplePopulations
Alzheimer's & Dementia
Plasma proteomics of cerebrovascular disease, cognitive decline, and clinical outcomes
Cohort study of 2,534 peopleCerebrovascular disease
CHEST Pulmonary
Dose-Response Effect of Physical Prehabilitation on Major Cardiac and Cerebrovascular Events and Disability Levels After Cardiac Surgery in Frail Patients
Randomised trial in 143 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Heterogeneity of Treatment Effect of Glucagon-Like Peptide 1 Receptor Agonists for Secondary Prevention of Cardiovascular Events in Type 2 Diabetes
Cohort study in peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Heterogeneity of Treatment Effect of Glucagon-Like Peptide 1 Receptor Agonists for Primary Prevention of Cardiovascular Events in Type 2 Diabetes
Cohort study of 648,505 peopleGLP-1 receptor agonists
AHA Scientific Sessions 2025 Abstract
Nocturnal Very Low Frequency of Heart Rate Variability Predicts Adverse Cardiovascular Events in Obese Individuals
Cohort study of 1,925 peopleHeart rate variability
AHA Scientific Sessions 2025 Abstract
Real-World Cardiorespiratory Impact of Respiratory Syncytial Virus (RSV) Vaccination in the USA: A Retrospective Propensity-Matched Analysis
Cohort study in peopleLung